Search Results

Carboplatin 25 mg  | >98%

AdipoGen Life Sciences

Potent platinum-based antineoplastic agent. Analog of cisplatin (Prod. No. AG-CR1-3590) with reduced nephrotoxicity and higher stability. Antitumor agent. Forms inter- and intrastrand DNA adducts/crosslinks, consequently blocking DNA replication and transcription and inducing cell death. Interferes with cell division by mitosis. The damaged DNA elicits DNA repair mechanisms, which in turn activate apoptosis when repair is […]

More Information Supplier Page

Cisplatin 250 mg  | >98%

AdipoGen Life Sciences

Potent platinum-based antineoplastic agent. Anticancer compound. Forms inter- and intrastrand DNA adducts/crosslinks, consequently blocking DNA replication and transcription and inducing cell death. Nephrotoxic when used in vivo. Potent chemoimmunotherapeutic. Stimulates the immune responses by activating macrophages and other cells of the immune system. Apoptosis inducer via p53-dependent and -independent mechanisms. Induces apoptosis through caspase-3 activation […]

More Information Supplier Page

Cisplatin 50 mg  | >98%

AdipoGen Life Sciences

Potent platinum-based antineoplastic agent. Anticancer compound. Forms inter- and intrastrand DNA adducts/crosslinks, consequently blocking DNA replication and transcription and inducing cell death. Nephrotoxic when used in vivo. Potent chemoimmunotherapeutic. Stimulates the immune responses by activating macrophages and other cells of the immune system. Apoptosis inducer via p53-dependent and -independent mechanisms. Induces apoptosis through caspase-3 activation […]

More Information Supplier Page

D-NMMA . monoacetate 25 mg  | >98%

AdipoGen Life Sciences

Cell permeable control compound for L-NMMA (Prod. No. AG-CR1-3578). Inactive, shows no NOS inhibitor activity. Useful tool to investigate non-specific L-NMMA activity.

More Information Supplier Page

D-NMMA . monoacetate 5 mg  | >98%

AdipoGen Life Sciences

Cell permeable control compound for L-NMMA (Prod. No. AG-CR1-3578). Inactive, shows no NOS inhibitor activity. Useful tool to investigate non-specific L-NMMA activity.

More Information Supplier Page

Amlexanox 50 mg  | >98%

AdipoGen Life Sciences

Antiallergic. Anti-inflammatory. Antagonizes the angiogenic and mitogenic activity of FGF-1 through S100A13. Inhibits FGF-1 release. Binds to HSP90. Inhibits C-terminal chaperone activity. Induces an increase in nonsense-containing mRNAs amount in treated cells, leading to the synthesis of functional full-length proteins in an efficient manner. Selective inhibitor of TANK-binding Kinase 1 (TBK1) and IKKepsilon. Reversibly lowers […]

More Information Supplier Page

Amlexanox 10 mg  | >98%

AdipoGen Life Sciences

Antiallergic. Anti-inflammatory. Antagonizes the angiogenic and mitogenic activity of FGF-1 through S100A13. Inhibits FGF-1 release. Binds to HSP90. Inhibits C-terminal chaperone activity. Induces an increase in nonsense-containing mRNAs amount in treated cells, leading to the synthesis of functional full-length proteins in an efficient manner. Selective inhibitor of TANK-binding Kinase 1 (TBK1) and IKKepsilon. Reversibly lowers […]

More Information Supplier Page

L-NMMA . monoacetate 1 g  | >99%

AdipoGen Life Sciences

Endothelium-derived relaxing factor inhibitor. Inhibits the generation of NO from arginine. Competitive, irreversible non-selective inhibitor of all three NOS I, II, and III isoforms (eNOS, iNOS and nNOS). Inhibits the synthesis of nitric oxide (NO) in a dose-dependent and enantiospecific fashion. Useful tool to study the role and the effects of NO in cardiovascular and […]

More Information Supplier Page

L-NMMA . monoacetate 100 mg  | >99%

AdipoGen Life Sciences

Endothelium-derived relaxing factor inhibitor. Inhibits the generation of NO from arginine. Competitive, irreversible non-selective inhibitor of all three NOS I, II, and III isoforms (eNOS, iNOS and nNOS). Inhibits the synthesis of nitric oxide (NO) in a dose-dependent and enantiospecific fashion. Useful tool to study the role and the effects of NO in cardiovascular and […]

More Information Supplier Page

L-NMMA . monoacetate 25 mg  | >99%

AdipoGen Life Sciences

Endothelium-derived relaxing factor inhibitor. Inhibits the generation of NO from arginine. Competitive, irreversible non-selective inhibitor of all three NOS I, II, and III isoforms (eNOS, iNOS and nNOS). Inhibits the synthesis of nitric oxide (NO) in a dose-dependent and enantiospecific fashion. Useful tool to study the role and the effects of NO in cardiovascular and […]

More Information Supplier Page